Marinol (dronabinol), a cannabinoid receptor 1(CB1) agonist, has been approved in the United States of America (USA) for the clinical treatment of nausea and vomiting, and anorexia caused by cytostasis or AIDS. This evidence concerns the gene CNR1 and AIDS.